Skip to main content
logo
Medicenna Therapeutics Corp. (TSX:MDNA)
Canada flag Canada · Delayed Price · Currency is CAD
0.4500
+0.0100 (2.27%)
Nov 9, 2026, 11:21 AM EST

Medicenna Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
4253771306192
Market Cap Growth
-67.45%-30.35%-40.82%111.36%-33.17%-66.08%
Enterprise Value
3643471082568
Last Close Price
0.440.640.981.860.881.65

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PB Ratio
24.2821.514.0124.952.084.40
P/TBV Ratio
24.9521.934.0325.232.084.42

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.060.050.01---
Net Debt / Equity Ratio
-3.34-2.47-1.29-3.27-1.14-0.99
Net Debt / EBITDA Ratio
0.250.271.210.912.060.92
Net Debt / FCF Ratio
0.300.341.491.042.650.87
Quick Ratio
1.111.396.216.344.958.33
Current Ratio
1.251.526.356.665.238.92
Return on Equity (ROE)
-227.57%-170.63%-97.22%-146.88%-39.94%-76.56%
Return on Assets (ROA)
-90.10%-76.07%-53.68%-42.00%-34.02%-42.75%
Return on Capital Employed (ROCE)
-1271.10%-750.00%-85.20%-114.80%-55.30%-107.90%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-48.98%-34.48%-15.40%-19.66%-16.40%-24.62%
FCF Yield
-46.31%-33.57%-21.56%-12.55%-20.65%-25.72%
Buyback Yield / Dilution
-6.75%-8.51%-10.10%-7.57%-19.25%-9.31%